Department of Molecular Cell Sciences, Univ. of Memphis, Memphis, TN 38152, USA.
Peptides. 2011 Feb;32(2):258-65. doi: 10.1016/j.peptides.2010.11.018. Epub 2010 Nov 30.
Non-specific binding of Y receptor agonists to intact CHO cells, and to CHO cell or rat brain particulates, is much greater for human neuropeptide Y (hNPY) compared to porcine peptide Y (pPYY), and especially relative to human pancreatic polypeptide (hPP). This binding of hNPY is reduced by alkali cations in preference to non-ionic chaotrope urea, while the much lower non-specific binding of pPYY is more sensitive to urea. The difference could mainly be due to the 10-16 stretch in 36-residue Y agonists (residues 8-14 in N-terminally clipped 34-peptides), located in the sector that contains all acidic residues of physiological Y agonists. Anionic pairs containing aspartate in the 10-16 zone could be principally responsible for non-specific attachments, but may also aid the receptor site binding. Two such pairs are found in hNPY, one in pPYY, and none in hPP. The hydroxyl amino acid residue at position 13 in mammalian PYY and PP molecules could lower conformational plasticity and the non-selective binding via intrachain hydrogen bonding. The acidity of this tract could also be important in agonist selectivity of the Y receptor subtypes. The differences point to an evolutionary reduction of promiscuous protein binding from NPY to PP, and should also be important for Y agonist selectivity within NPY receptor group, and correlate with partial agonism and out-of group cross-reactivity with other receptors.
与猪肽 YY(pPYY)相比,人类神经肽 Y(hNPY)与完整的 CHO 细胞以及 CHO 细胞或大鼠脑组织颗粒的非特异性结合,对 Y 受体激动剂的非特异性结合要强得多,与人类胰多肽(hPP)相比尤其如此。这种 hNPY 的结合被碱阳离子优先降低,而 pPYY 的非特异性结合较低,对尿素的敏感性更高。这种差异主要可能是由于 36 个残基 Y 激动剂(在 N 端截断的 34 肽中 8-14 位的残基)中的 10-16 延伸,位于包含所有生理 Y 激动剂酸性残基的区域。10-16 区带中含有天冬氨酸的阴离子对可能主要负责非特异性附着,但也可能有助于受体结合。hNPY 中有两个这样的对,pPYY 中有一个,hPP 中没有。哺乳动物 PYY 和 PP 分子中位置 13 的羟基氨基酸残基可能会降低构象灵活性和通过链内氢键的非选择性结合。该区域的酸度也可能对 Y 受体亚型的激动剂选择性很重要。这些差异表明从 NPY 到 PP 的混杂蛋白结合的进化减少,并且对于 NPY 受体组内的 Y 激动剂选择性也很重要,并且与部分激动剂和与其他受体的组外交叉反应性相关。